Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Mixed (cellular and humoral) acute rejection in elective biopsies received from the heart transplant recipients

S Zeglen, J Nozynski, E Wozniak-Grygiel, M Zakliczynski, A Laszewska, J Wojarski, R Wojnicz, R Przybylski, M Zembala

Ann Transplant 2009; 14(1): 63-63 :: ID: 880428


Background: Acute cellular heart transplant rejection is characterized by active lymphocytic infi ltration, whereas the humoral response presents the complement deposits in myocardial tissue. These two processes may be responsible for hemodynamic compromise in the first months after heart transplantation, when cellular rejection becomes faster and more severe than humoral rejection. The specific character of the first biopsy, because of the summarized nociceptive factors (e.g. rejection, warm ischemia, transportation time) should be pointed out. The aim of the study was to estimate the coexistence of humoral rejection in the first post-transplant biopsy with moderate cellular rejection, as an additional prognostic factor.
Material/Methods: A part of the first post-transplant endomyocardial biopsy
material was collected in a tissue freezing medium, whereas the remaining part was used for routine histology studies. The studied group included 13 biopsies (obtained from 11 men and 2 women; mean age 52.6±5.3 yr) with verified ISHLT mild/moderate rejection grade, whereas control group consisted of 11 biopsies (obtained from 8 men and 3 women; mean age 54.8±3.6 yr) with no signs of rejection. The complement deposits were determined immunohistochemically using anti-C4d antibodies (Quidel Corporation).
Results: None of the control group cases showed positive reaction, whereas in the studied group in 3 cases (3 men; 56.1±5.8 yr) the cellular infiltrates joined with regional positive anti-C4d expression. This expression occurred in all myocardial components adjacent to lymphocytic infiltrations. Survival rate was comparable in both clear cellular and mixed rejections. Relative rate of grade 3 rejection in post-transplant period was increased in patients with mixed rejection.
Conclusions: The term "mixed acute rejection" should be applied for such cases, when there is coincidence of the two forms of acute rejection and it seems to be associated with more frequent grade 3 rejection in the long term follow up.

Keywords: Heart Transplantation

Add Comment 0 Comments

In Press

12 Feb 2024 : Original article  

No Prognostic Impact of Graft-to-Recipient Weight Ratio on Hepatocellular Carcinoma Recurrence Following Li...

Ann Transplant In Press; DOI: 10.12659/AOT.942767  

21 Feb 2024 : Original article  

Use of LCP-Tacrolimus (LCPT) in Kidney Transplantation: A Delphi Consensus Survey of Expert Clinicians

Ann Transplant In Press; DOI: 10.12659/AOT.943498  

Most Viewed Current Articles

05 Apr 2022 : Original article  

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

12 Jan 2022 : Original article  

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

22 Nov 2022 : Original article  

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358